Controlled release of 5-fluorouracil from microporous zeolites

Abstract Zeolite particles with different pore diameter and particle size were loaded with the model anticancer drug 5-fluorouracil. The loaded zeolites were characterized by means of SEM, XRD, DSC, XPS, N2 physisorption and FT-IR. Higher loading of 5-FU was observed for NaX-FAU than BEA. Release st...

Full description

Saved in:
Bibliographic Details
Published inNanomedicine Vol. 10; no. 1; pp. 197 - 205
Main Authors Spanakis, Marios, PhD, Bouropoulos, Nikolaos, PhD, Theodoropoulos, Dimitrios, MSc, Sygellou, Lamprini, PhD, Ewart, Sinead, MSc, Moschovi, Anastasia Maria, PhD, Siokou, Angeliki, PhD, Niopas, Ioannis, PhD, Kachrimanis, Kyriakos, PhD, Nikolakis, Vladimiros, PhD, Cox, Paul A., PhD, Vizirianakis, Ioannis S., PhD, Fatouros, Dimitrios G., PhD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Zeolite particles with different pore diameter and particle size were loaded with the model anticancer drug 5-fluorouracil. The loaded zeolites were characterized by means of SEM, XRD, DSC, XPS, N2 physisorption and FT-IR. Higher loading of 5-FU was observed for NaX-FAU than BEA. Release studies were carried out in HCl 0.1 N. Release of 5-FU from NaX-FAU showed exponential-type behaviour with the drug fully released within 10 min. In the case of BEA, the kinetics of 5-FU shows a multi-step profile with prolonged release over time. Molecular dynamics simulations showed that diffusion of the drug molecule through the BEA framework is lower than for NaX-FAU due to increased van der Waals interaction between the drug and the framework. The effect of zeolitic particles on the viability of Caco-2 monolayers showed that the NaX-FAU particles cause a reduction of cell viability in a more pronounced way compared with the BEA particles. From the Clinical Editor This article describes zeolite-based nanoparticles in generating time-controlled release of 5-FU from zeolite preparations for anti-cancer therapy.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1549-9634
1549-9642
DOI:10.1016/j.nano.2013.06.016